AUSTRALIAN-BASED pharmaceutical ingredient producer, Alkaloids of Australia Pty Ltd, has entered guilty pleas to charges of criminal cartel conduct and price fixing.
The company, which produces scopolamine N-butylbromide, an ingredient in antispasmodic medications, allegedly colluded with overseas producers on prices, markets and bids for tenders, over a 10-year period, driving up prices for consumers.
Alkaloids' guilty plea followed a similar confession by the company's former export manager, Christopher Joyce (PD 26 Oct).
Alkaloids has been committed to the Federal Court of Australia for sentencing, and the matter is next listed for a case management hearing on 25 Nov 2021.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Nov 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Nov 21
